GlassScriptPhysician profile
Kyle J Childers
NPI 1992735559
$1,012.27
in general payments reported to CMS, 2019-2025
26 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.42 · 2020: $22.99 · 2021: $195 · 2022: $201 · 2023: $184 · 2024: $173 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $188.87 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $145.81 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.99 | 2019-2021 | |
| Glaxosmithkline, LLC. | $82.71 | 2019-2025 | Bexsero, Penmenvy, Shingrix |
| Merck Sharp & Dohme LLC | $59.32 | 2021-2024 | Vaxneuvance, Gardasil 9, Rotateq |
| Cipher Pharmaceuticals US LLC | $42.80 | 2025 | Natroba, Spinosad |
| Sanofi-Aventis U.S. LLC | $37.33 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $34.48 | 2025 | Jornay Pm |
| Biohaven Pharmaceuticals, INC. | $28.18 | 2021 | |
| Novo Nordisk INC | $26.15 | 2023 | Wegovy |
| Pfizer INC. | $25.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $22.92 | 2021 | |
| Tris Pharma INC | $22.37 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $21.38 | 2022 | |
| Lilly USA, LLC | $18.50 | 2025 | Jardiance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.48 | 2024 | Veozah |
| Xeris Pharmaceuticals, INC. | $17.87 | 2023 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $16.87 | 2022 | |
| Abbott Laboratories | $14.74 | 2023 | Freestyle Libre 3 |
| Vertical Pharmaceuticals, LLC | $14.67 | 2024 | Relexxii |
| Amarin Pharma, INC. | $14.37 | 2019 | |
| Cranial Technologies, INC | $13.56 | 2024 | Doc Band |
| Exact Sciences Corporation | $13.51 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $13.00 | 2023 | Aptima |
| Biogen, INC. | $12.20 | 2021 | |
| Genentech USA, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Childers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.